152 related articles for article (PubMed ID: 24408046)
21. The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis.
Tam HH; Collins DJ; Brown G; Chau I; Cunningham D; Leach MO; Koh DM
Br J Radiol; 2013 Oct; 86(1030):20130281. PubMed ID: 23995873
[TBL] [Abstract][Full Text] [Related]
22. Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging.
Marugami N; Tanaka T; Kitano S; Hirohashi S; Nishiofuku H; Takahashi A; Sakaguchi H; Matsuoka M; Otsuji T; Takahama J; Higashiura W; Kichikawa K
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):638-46. PubMed ID: 19238482
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.
Wagner M; Ronot M; Doblas S; Giraudeau C; Van Beers B; Belghiti J; Paradis V; Vilgrain V
Eur Radiol; 2016 Jan; 26(1):206-15. PubMed ID: 25933743
[TBL] [Abstract][Full Text] [Related]
24. Diffusion-Related MRI Parameters for Assessing Early Treatment Response of Liver Metastases to Cytotoxic Therapy in Colorectal Cancer.
Kim JH; Joo I; Kim TY; Han SW; Kim YJ; Lee JM; Han JK
AJR Am J Roentgenol; 2016 Sep; 207(3):W26-32. PubMed ID: 27303858
[TBL] [Abstract][Full Text] [Related]
25. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
[TBL] [Abstract][Full Text] [Related]
26. Apparent diffusion coefficients (ADC) in response assessment of transarterial radioembolization (TARE) for liver metastases of neuroendocrine tumors (NET): a feasibility study.
Katharina Ingenerf M; Karim H; Fink N; Ilhan H; Ricke J; Treitl KM; Schmid-Tannwald C
Acta Radiol; 2022 Jul; 63(7):877-888. PubMed ID: 34225464
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.
Xu HD; Zhang YQ
Neoplasma; 2017; 64(3):430-436. PubMed ID: 28253722
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.
Barabasch A; Kraemer NA; Ciritsis A; Hansen NL; Lierfeld M; Heinzel A; Trautwein C; Neumann U; Kuhl CK
Invest Radiol; 2015 Jun; 50(6):409-15. PubMed ID: 25763526
[TBL] [Abstract][Full Text] [Related]
29. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases.
Cui Y; Zhang XP; Sun YS; Tang L; Shen L
Radiology; 2008 Sep; 248(3):894-900. PubMed ID: 18710982
[TBL] [Abstract][Full Text] [Related]
30. Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer.
Heijmen L; ter Voert EE; Oyen WJ; Punt CJ; van Spronsen DJ; Heerschap A; de Geus-Oei LF; van Laarhoven HW
PLoS One; 2015; 10(4):e0120823. PubMed ID: 25831053
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study.
Shao GL; Zheng JP; Guo LW; Chen YT; Zeng H; Yao Z
Medicine (Baltimore); 2017 Jan; 96(3):e5518. PubMed ID: 28099329
[TBL] [Abstract][Full Text] [Related]
32. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma.
Yuan Z; Ye XD; Dong S; Xu LC; Xu XY; Liu SY; Xiao XS
Eur J Radiol; 2010 Jul; 75(1):e9-14. PubMed ID: 19540083
[TBL] [Abstract][Full Text] [Related]
33. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of ADC measurements in predicting overall survival in patients undergoing
Alis D; Durmaz ESM; Gulsen F; Bas A; Kabasakal L; Sager S; Numan F
Clin Imaging; 2019; 57():124-130. PubMed ID: 31220677
[TBL] [Abstract][Full Text] [Related]
35. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
[TBL] [Abstract][Full Text] [Related]
36. Neuroendocrine liver metastases: Value of apparent diffusion coefficient and enhancement ratios for characterization of histopathologic grade.
Besa C; Ward S; Cui Y; Jajamovich G; Kim M; Taouli B
J Magn Reson Imaging; 2016 Dec; 44(6):1432-1441. PubMed ID: 27227756
[TBL] [Abstract][Full Text] [Related]
37. Changes in apparent diffusion coefficient and pathological response in colorectal liver metastases after preoperative chemotherapy.
Eriksson S; Bengtsson J; Torén W; Lätt J; Andersson R; Sturesson C
Acta Radiol; 2023 Jan; 64(1):51-57. PubMed ID: 35084232
[TBL] [Abstract][Full Text] [Related]
38. [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
Yuan Z; Ye XD; Dong S; Xu LC; Sun ZC; Xiao XS
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):293-7. PubMed ID: 19615287
[TBL] [Abstract][Full Text] [Related]
39. Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and
Uutela A; Ovissi A; Hakkarainen A; Ristimäki A; Lundbom N; Kallio R; Soveri LM; Salminen T; Ålgars A; Halonen P; Ristamäki R; Nordin A; Blanco Sequeiros R; Rinta-Kiikka I; Lantto E; Virtanen J; Pääkkö E; Liukkonen E; Saunavaara J; Ryymin P; Lammentausta E; Osterlund P; Isoniemi H;
ESMO Open; 2021 Aug; 6(4):100208. PubMed ID: 34325107
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.
Anzidei M; Napoli A; Sacconi B; Boni F; Noce V; Di Martino M; Saba L; Catalano C
Radiol Med; 2016 Dec; 121(12):905-915. PubMed ID: 27567615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
